Wellington Management Group LLP Bio Xcel Therapeutics, Inc. Transaction History

Wellington Management Group LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$2.32 - $5.51 $85,733 - $203,616	36,954 New	36,954 $109,000
Q3 2023 Nov 14, 2023	SELL	$2.49 - $11.85 $2.9 Million - $13.8 Million	-1,166,390 Reduced 96.93%	36,954 $93,000
Q2 2023 Aug 14, 2023	SELL	$6.39 - $28.58 $838,764 - $3.75 Million	-131,262 Reduced 9.84%	1,203,344 $8.01 Million
Q1 2023 May 12, 2023	BUY	$17.7 - $33.24 $23.6 Million - $44.4 Million	1,334,606 New	1,334,606 $24.9 Million
Q1 2022 May 16, 2022	BUY	$15.0 - $22.83 $26,280 - $39,998	1,752 Added 7.11%	26,394 $552,000
Q4 2021 Feb 11, 2022	BUY	$20.12 - $35.09 $495,797 - $864,687	24,642 New	24,642 $501,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.